What We're Reading: Page
Industry reads hand-picked by our editors
Sep 13, 2021
-
BioCentury
Fred Frank, co-founder of the biotech industry, is dead at 89
-
Reuters
Britain begins world's largest trial of blood test for 50 types of cancer
-
STAT
A vaccine veteran steps away from the NIH, looking out toward the world
-
FiercePharma
Bausch pays whopping $300M to settle Glumetza pay-for-delay lawsuit after 800% price hike
Sep 10, 2021
-
Associated Press
Sweeping new vaccine mandates for 100 million Americans
-
The Wall Street Journal
Theranos Trial Paused Over Possible Juror Covid-19 Exposure
-
The Economist
Why scientists are deliberately infecting volunteers with Covid-19
-
Endpoints News
Martin Shkreli to go toe-to-toe with new FTC chair over Daraprim price spikes
Sep 09, 2021
-
The Wall Street Journal
White House Unveils Plan to Cut Prescription-Drug Prices
-
STAT
FDA rejection of Humanigen drug points to industry challenge in Covid fight
-
Evaluate Vantage
Centessa takes a step towards a new hemophilia mechanism
Sep 08, 2021
-
Bloomberg
Feared Wall Street Fund Elliott Is Targeting GSK. What Does It Want?
-
FierceBiotech
SPAC Attack: The 10 biggest in biotech
-
Financial Times
Top Pfizer scientist defends Covid vaccine booster push and jab’s potency
-
Smithsonian Magazine
Frog Foam May Help Deliver Drugs to Human Skin
Sep 07, 2021
-
Bloomberg
One Vaccine Makes More Antibodies Than Another. Does it Matter?
-
MIT Technology Review
Meet Altos Labs, Silicon Valley’s latest wild bet on living forever
-
FiercePharma
Crippled by opioid-crisis litigation, Mallinckrodt settlement brings company closer to reorganization
-
STAT
CEPI warns of major hurdle to developing new Covid-19 vaccines
Sep 03, 2021
Sep 02, 2021
-
Associated Press
Judge conditionally approves Purdue Pharma opioid settlement
-
The Boston Globe
MassBio taps another state lawmaker as its leader
-
The Washington Post
House committees step up investigation into FDA approval of controversial Alzheimer’s drug
-
Bloomberg Law
FDA Regains Rulemaking Authority in Reversal of Trump-Era Move
Previous
